Page 13 - கிரேடி நினைவகம் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tags » Emory University is participating in a study evaluating immune responses to COVID-19 vaccines, when the vaccines are administered during pregnancy or within two months after delivery. The study, called SARS-CoV-2 Vaccines in Pregnancy and Postpartum or MOMI-Vax, is sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. MOMI-Vax is being conducted by the NIAID-funded Infectious Diseases Clinical Research Consortium (IDCRC).  MOMI-Vax is open to people who have received any of the FDA-authorized COVID-19 vaccines. The early COVID-19 vaccine clinical trials generally excluded pregnant women, so there is limited data on immune responses for this special population. However, after the FDA authorized the vaccines, regulators gave people who were pregnant or soon to be pregnant the option of choosing to get the vaccines. Tens of thousands of pregnant and breastfeeding people across the country have b

Martina badellNadine rouphaelEvan andersonEmory universityNational institute of allergyNational institutes of healthDrug administrationEmory children centerInfectious diseases clinical research consortiumDivision of maternalHope clinic of emory vaccine centerEmory university hospitalNational instituteInfectious diseasesNational institutesHope clinic